Biohaven surges as genetic disease drug meets main study goal
Go back to Biohaven surges as genetic disease drug meets main study goal| (NYSE: BHVN) | Delayed: 12.71 -0.08 (0.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.79 | 52 Week High | $ | |||
| Open | $13.03 | 52 Week Low | $ | |||
| Day High | $13.37 | P/E | N/A | |||
| Day Low | $12.58 | EPS | $ | |||
| Volume | 2,863,289 | |||||
